Listed

IGC Pharma, Inc.

IGCNYSECIK 1326205HealthcareFiscal year ends Dec 31

Reports and events: 271 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

IGC Pharma, Inc., Reports and events
FiledFormWhat it isAccession number
2012-07-1617:06 ET10-KAnnual reportPeriod 2012-03-310001185185-12-001484
2012-06-2715:09 ET8-K2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits0001185185-12-001394
2012-06-2511:07 ET8-K2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits0001185185-12-001377
2012-06-0116:30 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001185185-12-001266
2012-05-1614:40 ETS-1/ARegistration statement, amended0001185185-12-001131
2012-04-2716:03 ETS-1/ARegistration statement, amended0001185185-12-000859
2012-04-0614:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001185185-12-000718
2012-03-0516:20 ETS-1Registration statement0001185185-12-000320
2012-02-1608:08 ET10-QQuarterly reportPeriod 2011-12-310001185185-12-000256
2012-02-0908:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001185185-12-000200
2012-02-0608:02 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001185185-12-000177
2012-01-2716:42 ET8-K5.02 Departure or appointment of officers or directors0001185185-12-000135
2012-01-0613:51 ET8-K2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001185185-12-000032
2011-12-3016:36 ET8-K5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001185185-11-002320
2011-12-2914:38 ET8-K5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001185185-11-002311
2011-12-0909:56 ETDEF 14AProxy statementPeriod 2011-12-280001185185-11-002176
2011-11-1817:19 ET10-QQuarterly reportPeriod 2011-09-300001185185-11-002076
2011-11-0320:50 ET10-K/AAnnual report, amendedPeriod 2011-03-310001185185-11-001808
2011-11-0217:15 ET8-K5.07 Shareholder vote results0001185185-11-001805
2011-10-1918:40 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001185185-11-001744
2011-10-1416:30 ET8-K5.07 Shareholder vote results0001185185-11-001726
2011-09-2916:15 ET8-K5.07 Shareholder vote results0001185185-11-001654
2011-09-0120:23 ET8-K5.07 Shareholder vote results0001185185-11-001468
2011-08-1817:13 ET10-QQuarterly reportPeriod 2011-06-300001185185-11-001390
2011-08-1117:23 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001185185-11-001197
2011-08-0107:52 ETDEF 14AProxy statementPeriod 2011-08-250001185185-11-001086
2011-07-2717:13 ET10-K/AAnnual report, amendedPeriod 2011-03-310001185185-11-001051
2011-07-1518:09 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001185185-11-001003
2011-07-1416:57 ET10-KAnnual reportPeriod 2011-03-310001185185-11-001000
2011-06-1516:22 ET8-K4.02 Non-reliance on financial statements; 9.01 Financial statements and exhibits0001185185-11-000883
2011-03-2517:22 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001185185-11-000368
2011-03-1116:45 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001185185-11-000295
2011-02-2516:32 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001185185-11-000228
2011-02-2409:37 ET8-K3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits0001185185-11-000224
2011-02-2310:05 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001185185-11-000211
2011-02-2217:26 ET10-QQuarterly reportPeriod 2010-12-310001185185-11-000208
2011-02-0114:54 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001185185-11-000108
2011-01-2813:41 ET10-K/AAnnual report, amendedPeriod 2010-03-310001185185-11-000099
2010-12-0908:08 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001185185-10-001439
2010-12-0310:07 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001185185-10-001415
2010-11-1917:28 ET10-QQuarterly reportPeriod 2010-09-300001185185-10-001365
2010-11-1011:11 ETS-1/ARegistration statement, amended0001185185-10-001217
2010-11-0417:14 ETS-1/ARegistration statement, amended0001185185-10-001197
2010-10-2717:03 ETS-1/ARegistration statement, amended0001185185-10-001165
2010-10-0117:30 ETS-1/ARegistration statement, amended0001185185-10-001090
2010-08-1616:55 ET8-K5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001185185-10-000923
2010-08-1619:31 ET10-QQuarterly reportPeriod 2010-06-300001185185-10-000901
2010-07-2317:24 ETDEF 14AProxy statementPeriod 2010-08-160001185185-10-000817
2010-07-1416:22 ET10-KAnnual reportPeriod 2010-03-310001185185-10-000790
2010-05-2709:26 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001185185-10-000646

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 6, 2026, 16:27 ET. Listed shows no prices and gives no investment advice.